Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

@xconomy.com 4 years ago

Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B

@xconomy.com 4 years ago

UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma

@xconomy.com 5 years ago

With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy

@xconomy.com 5 years ago

Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 5 years ago

Boston Scientific Continues M&A Streak with $202M Deal for Cryterion

@xconomy.com 5 years ago

With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines

@xconomy.com 5 years ago

Teladoc Buys Advance Medical for $352M to Expand Telehealth Services